FDA warns of risk of surgical mesh used to repair pelvic organ prolapse

The U.S. Food and Drug Administration has issued a warning for surgical placement of mesh through the vagina to repair pelvic organ transplant. Adverse effects include tissue erosion, pain, infection, bleeding, and pain during sexual intercourse. The FDA also stated that the mesh “may expose patients to greater risk than other surgical options.” Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here